Related News
Work of Two Medical Students Recognized at ArMA Poster Symposium
Monday, June 30, 2025
CATalyst Chat Focuses on the Fundamentals of Hearing Loss
Wednesday, June 18, 2025
Technology Developed by ANBM to be Utilized for New Drug Discovery Program
Tuesday, June 03, 2025MGC Scientists to work with UA Researchers
The University of Arizona’s Center for Applied NanoBioscience and Medicine (ANBM) has signed the first five-year phase of an innovation partnership agreement with the Mitsubishi Gas Chemical Company (MGC) in Japan.
In addition to the partnership agreement, Mitsubishi Gas Chemical is contributing to the Center with an unrestricted gift to support the operations and lab’s research projects. The Center, housed at the University of Arizona College of Medicine – Phoenix, will also have access to state-of-the-art analytical equipment and specialty engineers at the MGC Tokyo Research Laboratory. Visiting scientists from Mitsubishi Gas Chemical will be assigned a two-year rotation in Arizona to collaborate with researchers at the Center, which is led by professor and director Frederic Zenhausern, PhD, MBA.
“Our innovation engagement with MGC will nurture original ideas to accelerate progress in translational discoveries for changing the game in global health care technologies,” Dr. Zenhausern said.
MCG Group does business in a wide range of fields, from basic chemicals to specialty and advanced materials. Toshikiyo Kurai, representative director and president of MCG Group, said the company hopes to develop new products in the health care sector.
The company’s mission is to “contribute to society growth and harmony by creating a wide range of value through chemistry,” he said.
“I am hoping for our success in the creation of novel products by combining the basic technology platform of Dr. Zenhausern’s group and our business platform,” he said.
The mission of the Center for Applied NanoBioscience and Medicine is to develop technologies for automating and miniaturizing the processing of biological samples for delivering simpler diagnostic tests, accessing biomarkers more readily and bringing earlier and more precise health care. The team at the Center has participated in more than $250 million in sponsored projects over 10 years and has transferred several technologies to industry, including four startup companies. The value of its portfolio of projects is more than $8 million.
The Center has local clinical research collaborations with the UA/Dignity Health Cancer Center, the Maricopa Health Center, HonorHealth Research Institute and TGen, among others. It also is involved with several academic strategic partnerships, for example with the Duke Fitzpatrick Photonics Center at Duke University.
Based in Tokyo, Mitsubishi Gas Chemical is a leading chemicals group with a strong platform of proprietary technology.
Media Contact:
Marian Frank
Phone: 602-827-2022
About the College
Founded in 2007, the University of Arizona College of Medicine – Phoenix inspires and trains exemplary physicians, scientists and leaders to optimize health and health care in Arizona and beyond. By cultivating collaborative research locally and globally, the college accelerates discovery in a number of critical areas — including cancer, stroke, traumatic brain injury and cardiovascular disease. Championed as a student-centric campus, the college has graduated more than 900 physicians, all of whom received exceptional training from nine clinical partners and more than 2,700 diverse faculty members. As the anchor to the Phoenix Bioscience Core, the college prides itself on engaging with the community, fostering education, inclusion, access and advocacy.